EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management

Anna Linda Zignego, Laura Gragnani iD, Marcella Visentini, Riccardo Bomben, Luca Arcaini, Clodoveo Ferri, Valter Gattei, Cesare Mazzaro

Journal of Internal Medicine · 2026-02 · 299 (2) · 196-215

DOI: 10.1111/joim.70042 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Internal Medicine, online erschienen am 26.11.2025. Verfasst von Anna Linda Zignego und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Cryoglobulinemia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryoglobulinemia (CG) is defined by the presence of serum immunoglobulins that precipitate below 37°C and redissolve upon rewarming. It is classified into three types based on immunoglobulin composition. Type I, a rare form, involves monoclonal IgM or IgG and is linked to lymphoproliferative disorders. Types II and III are known as mixed CG (MC): Type II consists of polyclonal IgG and monoclonal IgM with rheumatoid factor (RF) activity, whereas Type III includes polyclonal IgG and polyclonal IgM with RF activity. MC is predominantly associated with hepatitis C virus (HCV) infection and involves B‐cell lymphoproliferation and autoantibody production. CG may lead to systemic vasculopathy, ranging from mild symptoms (purpura, asthenia, and arthralgia) to severe complications such as skin ulcers, peripheral neuropathy, renal involvement, and non‐Hodgkin lymphoma. Compared to MC, Type I is more often marked by severe cutaneous involvement (ulcers, gangrene), hyperviscosity, and a higher risk of morbidity due to the underlying hematologic malignancy. Management of Type I requires control of vasculopathy and treatment of the hematologic neoplasm, whereas MC demands antiviral therapy in all HCV‐associated or hepatitis B virus–associated cases. Severe vasculopathy in both types may benefit from corticosteroids, immunomodulators, anti‐CD20 monoclonal antibodies, and plasma exchange. A multidisciplinary approach is essential for addressing both etiology and complications, thereby improving outcomes. This review summarizes the pathophysiology, clinical features, recent etiopathogenetic insights, and therapeutic advances related to the various forms of CG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryoglobulinemiaHumansHepatitis C

Stichwörter der Autor:innen

Cryoglobulinemia Type IType II and Type III mixed cryoglobulinemiaautoimmune disordershepatitis B virushepatitis C viruslymphoproliferative disorders

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Pisa, Italy.
  • Department of Translational and Precision Medicine, Sapienza University of Rome, Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
  • Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Pordenone, Italy.
  • Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

ORCID-Profile: Laura Gragnani

Zitieren

APA

Zignego, A. L., Gragnani, L., Visentini, M., Bomben, R., Arcaini, L., Ferri, C., Gattei, V., & Mazzaro, C. (2026). Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management. Journal of Internal Medicine, 299(2), 196-215. https://doi.org/10.1111/joim.70042

Vancouver

Zignego AL, Gragnani L, Visentini M, Bomben R, Arcaini L, Ferri C, et al. Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management. Journal of Internal Medicine. 2026;299(2):196-215. doi:10.1111/joim.70042

BibTeX
@article{Zignego2026,
  author = {Zignego, Anna Linda and Gragnani, Laura and Visentini, Marcella and Bomben, Riccardo and Arcaini, Luca and Ferri, Clodoveo and Gattei, Valter and Mazzaro, Cesare},
  title = {Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management},
  journal = {Journal of Internal Medicine},
  year = {2026},
  volume = {299},
  number = {2},
  pages = {196--215},
  doi = {10.1111/joim.70042}
}
Kostenlos starten →